These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19235913)

  • 1. Association between genetic variants in myosin IXB and Crohn's disease.
    Cooney R; Cummings JR; Pathan S; Beckly J; Geremia A; Hancock L; Guo C; Morris A; Jewell DP
    Inflamm Bowel Dis; 2009 Jul; 15(7):1014-21. PubMed ID: 19235913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
    Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene.
    Cummings JR; Cooney R; Pathan S; Anderson CA; Barrett JC; Beckly J; Geremia A; Hancock L; Guo C; Ahmad T; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Aug; 13(8):941-6. PubMed ID: 17455206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: a study in Crohn's disease.
    Prager M; Durmus T; Büttner J; Molnar T; de Jong DJ; Drenth JP; Baumgart DC; Sturm A; Farkas K; Witt H; Büning C
    Scand J Gastroenterol; 2014 Oct; 49(10):1191-200. PubMed ID: 25098938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of genetic variation in the MYO9B gene in Crohn's disease.
    Wolters VM; Xu W; Zhao X; Walters TD; Griffiths AM; Silverberg MS; Muise AM
    Hum Immunol; 2011 Jul; 72(7):592-7. PubMed ID: 21515326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
    Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease.
    Beckly JB; Hancock L; Geremia A; Cummings JR; Morris A; Cooney R; Pathan S; Guo C; Jewell DP
    Inflamm Bowel Dis; 2008 Apr; 14(4):500-7. PubMed ID: 18200509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.
    Urcelay E; Mendoza JL; Martinez A; Fernandez L; Taxonera C; Diaz-Rubio M; de la Concha EG
    World J Gastroenterol; 2005 Feb; 11(8):1187-92. PubMed ID: 15754402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.